TheEdgeResearch
Home / Stocks / IDX.AX

Integral Diagnostics Limited (IDX.AX)

ASX Healthcare Medical - Diagnostics & Research
$2.26 ▲ +1.80%
Market Cap
$843.1M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.14
52-Wk Range
1.905-3.07
CEO
Ian Kadish
Country
AU
Currency
AUD

Integral Diagnostics Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Melbourne, VIC, AU. The stock last traded at $2.26, up 1.80% on the session, giving a market capitalisation of $843.1M. Its beta of 0.14 implies it has historically moved less than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
3,000
IPO date
2015-10-20
Headquarters
Melbourne, VIC, AU
About Integral Diagnostics Limited

Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services. These services are delivered to general practitioners, medical specialists, allied health professionals, and their patients across Australia and New Zealand. The company manages its service delivery through a network of 67 radiology clinics. Integral Diagnostics was incorporated in 2008 and maintains its primary corporate office in Melbourne, Australia.

Comparable companies

Integral Diagnostics Limited is most often compared with the following Healthcare names:

ACL.AXHLS.AXLDX.AXMVF.AXNAN.AXOCA.AXPGC.AXPNV.AXPYC.AX
More research on IDX.AX
IDX.AX technical analysis IDX.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →